~ Amenorrhea ~
¡@
Decision tree for evaluation of amenorrhea
v Classification:
? No menses by 16 y/o with presence of 2o sexual characteristic, or
‚ No visible 2o sexual characteristic by 14 y/o
Absence of menstruation for three normal menstrual cycles or 6 months
¡@
v Work-up for Amenorrhea:
? Hx: G?P?, LMP?, OBS/GYN Hx, medical diseases, operation Hx, etc.
‚ PE, PV, and/or PR:
2o sexual characteristic (breast, pubic hair, axillary hair, etc.)
uterus, cervix, vagina, external genitalia, etc.
ƒ Lab. Survey: EIA, FSH, TSH, PRL, E2, etc.
„ Image Study: ultrasound, HSG, CT, MRI,etc.
¡@
v Amenorrhea without Secondary Sexual Characteristic:
Abnormal Physical Examination:
5a -reductase deficiency in XY individual
17-20 desmolase deficiency in XY individual (rare)
17a -hydroxylase deficiency in XY individual
Hypergonadotropic Hypogonadism:
(disorders of ovaries, either genetic origin, enzymatic origin, or other origin)
Gonadal dysgenesis (eg. Turner¡¦s syndrome): the most common cause
Pure gonadal dysgenesis
Partial deletion of X chromosome
Sex chromosome mosaicism
Environmental and therapeutic ovarian toxins
17a -hydroxylase deficiency in XX individual
Galactosemia
Others
Hypogonadotropic Hypogonadism:
(disorders of hypothalamic origin or pituitary origin)
Physical delay: the most common cause
Kallman¡¦s syndrome: insufficient pulsatile secretion of GnRH
Central nervous system tumors: most commonly, craniopharyngioma
Hypothalamic/pituitary dysfunction
? cyclic:
premarin (0.625) 0.625 mg qd ´ 25 ds
provera (5) 5-10 mg qd ´ 12-14 ds
‚ continuous
Add corticosteroid replacement
Eg. craniopharyngioma è radiotherapy
`
v Amenorrhea with Secondary Sexual Characteristic
and Anatomic Abnormalities:
M
ullerian anomalies:Imperforate hymen: bulging membrane during valsalva maneuver
Transverse vaginal septum
Mayer-Rokitansky-K
uster-Hauser syndrome:ie. hypoplasia or absence of the uterus, cervix, and or vagina
PE, ultrasound or MRI, IVP (to detect concomitant renal anomaly)
Androgen insensitivity:
male pseudohermaphrodites, 46XY
absent pubic hair and axillary hair
True hermaphrodites: Both male and female gonadal tissue is present.
Absent endometrium
Asherman¡¦s syndrome: diagnosed by HSG or hysteroscopy
Secondary to prior uterine or cervical surgery
Currettage, especially postpartum
Cone biopsy
Loop electroexcision procedure
Secondary to infections
Pelvic inflammatory disease
IUD-related
Tuberculosis endometrial
Schistosomiasis culture
progressive dilation, if fails, then McIndoe split thickness graft technique
Lysis of adhesion, IUD insertion (or pediatric Foley) 7-10 days post-operatively,
Systemic broad-spectrum antibiotics, 2-month course of high-dose estrogen
¡@
v Amenorrhea with Secondary Sexual Characteristic and Nonanatomic Causes:
Genetic disorders: mosaicism of an XO or XY cell line, deletion of a portion of
X chromosome, 47XXX.
Iatrogenic causes: radiation, chemotherapy, surgical alteration of ovarian blood supply.
Infections
Autoimmune disorders
Galactosemia (mild form or heterozygote)
Savage syndrome: FSH receptors are absent or a postreceptor defect exists
Cigarette smoking
Idiopathic
Hypothalamic/pituitary:
Craniopharynigioma
Germinoma
Tubercular granuloma
Sarcoid granuloma
Dermoid cyst
Pituitary:
Nonfunctional adenoma
Hormone-secreting ademonas:
Prolactinoma
Cushing¡¦s disease
Acromegaly
Primary hyperthyroidism
Infarction
Lymphocytic hypophysitis
Surgical or radiological ablations
Sheehan¡¦s syndrome: postpartum necrosis of the pituitary
Diabetic vasculitis
Variable estrogen status:
Anorexia nervosa
Exercise-induced
Stress-induced
Pseudocyesis
Malnutrition
Chronic diseases:
DM, renal disorders, pulmonary disorders, liver disease,
chronic infections, Addison¡¦s disease
Hyperprolactinemia
Thyroid dysfuction
Euestrogenic states:
Obesity
Hyperandrogenism:
Polycystic ovarian syndrome
Cushing¡¦s syndrome
Congenital adrenal hyperplasia
Androgen-secreting adrenal tumors
Androgen-secreting ovarian tumors
Granulosa cell tumor
Idiopathic
TSH and prolactin levels:
¡P If elevated TSH and prolactin level are found, the hypothyroidism
should be treat before hyperprolactinemia is treated
FSH level
Estrogen status: progesterone challenge test
¡P Provera (5) 5 or 10 mg for 10 days, or
¡P progesterone 100-200 mg im.
oral contraceptives: decreasing ovarian androgen production,
increasing circulating levels of sex hormone-binding globulin
spironolactone: decreasing androgen production,
competing with androgen at the androgen-receptor level
Clomiphene citrate:
The usual first choice
Effective only in patients with adequate levels of estrogen, FSH, and PRL
Contraindications: pregnancy, liver disease, preexisting ovarian cysts.
Dosage: Clomiphene 50 mg qd since D5 for 5 days
HMG:
When clomiphene fails, or hypogonadotropic hypoestrogenic anovulation
GnRH:
Effective in patients with low level of estrogen and gonadotropins
Filename: Amenorrhea
¡@